Tag: TCT 2016
The implications of ABSORB II three-year results for the future of bioresorbable scaffolds
The idea of a fully b...
Medinol reports positive clinical results for Elunir elastomer-coated drug-eluting stent
Twelve-month clinical res...
TCT 2016: Three-year data fail to show Absorb to be superior or even non-inferior to Xience
According to the thre...
TCT 2016: Different endpoints may have led to different outcomes for left main PCI
Two randomised contro...
TCT 2016: Transfemoral TAVI improves quality of life in intermediate-risk patients
Data presented at the...
TCT 2016: “Excellent” rates of late lumen loss with Desolve bioresorbable scaffold
Six-month clinical data f...
TCT 2016: Women and minorities have a significantly higher risk of death after PCI than white men
Data from the PLATINU...
TCT 2016: SENTINEL trial fails to meet overall primary efficacy endpoint but does in adjusted model
The SENTINEL trial, w...
TCT 2016: Physicians discuss their positive experiences of using a metallic scaffold
At a symposium at the...
TCT 2016: First-in-human data shows Medtronic’s drug-filled stent to be non-inferior to Resolute
Results of the REVELU...
TCT 2016: FDA approve Amplatzer PFO occluder device ahead of first report investigation presentation
The FDA has approved ...
TCT 2016: All comers study finds no differences between Orsiro, Synergy and Resolute Integrity
BIO-RESORT, presented at ...
TCT 2016: First live case featuring Desolve NXT scaffold to be presented
Elixir Medical has announ...
TCT 2016: Breakfast symposium to explore robotic therapy in interventional cardiology
Corindus Vascular Rob...
TCT 2016: Tryton Medical to hold clinical symposium on treatment of complex bifurcation lesions
Tryton Medical has an...
